Oncogene-dependent function of BRG1 in hepatocarcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Hepatocellular carcinoma (HCC) is a major primary liver cancer with diverse genomic subtypes.
• BRG1, a component of SWI/SNF chromatin-remodeling complexes encoded by SMARCA4, is implicated in HCC.
• Previous studies suggest BRG1 overexpression promotes HCC, but its precise functions are unclear.

Purpose of the Study:

• To investigate the functional roles of BRG1 in human hepatocellular carcinoma (HCC) and mouse models.
• To elucidate the dual oncogenic and tumor-suppressing activities of BRG1 in hepatocarcinogenesis.

Main Methods:

• Analysis of BRG1 expression in human HCC samples.
• Utilized TCGA data to correlate BRG1 levels with cancer pathways.
• Employed a murine HCC model with c-MYC overexpression.
• Investigated the effects of Brg1 gene ablation and co-expression with c-Met or NRAS^V12 in mice.

Main Results:

• BRG1 is overexpressed in most human HCC samples, particularly those with poor prognosis.
• BRG1 expression correlates positively with cell cycle and negatively with metabolic pathways in TCGA data.
• Brg1 ablation completely repressed c-MYC-induced HCC formation in mice.
• Concomitant deletion of Brg1 with c-Met or NRAS^V12 overexpression triggered HCC formation in mice.

Conclusions:

• BRG1 exhibits context-dependent roles in hepatocarcinogenesis, acting as both an oncogene and a tumor suppressor.
• The function of BRG1 in HCC is determined by the specific oncogenic stimuli present during tumor development.